Drug and Device Issues Related to COVID-19

11:00 AM - 01:00 PM ET
08:00 AM - 10:00 AM PT

From the start of COVID-19 pandemic, the FDA provided guidance to members of the drug and biologic industries. Now the FDA is looking toward the future, providing guidance on clinical trials and compliance.

FDA partners Kathleen Sanzo, Jacqueline Berman, Michele Buenafe and Dennis Gucciardo will discuss various issues related to drugs and devices and COVID-19.

CLE credit: Please see the PBI website for detailed CLE credit information.